首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1529933

個人化細胞治療市場：依細胞類型、依治療領域、依最終使用者、按地區

Personalized Cell Therapy Market, By Cell Type, By Therapeutic Area, By End Users, By Geography

出版日期: 2024年07月19日 | 出版商:

Coherent Market Insights | 英文 157 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球個人化細胞治療市場規模為141.2億美元，預計到2031年將達到650.1億美元，2024年至2031年複合年成長率為24.4%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	141.2億美元
實際資料	2019-2023	預測期	2024-2031
預測期，2024-2031年複合年成長率：	24.40%	2031 年金額預測	650.1億美元

圖：2024 年按地區分類的個人化細胞治療市場佔有率(%)

推動全球個人化細胞治療市場成長的是主要企業增加研發投資，以開發先進的細胞療法來治療各種慢性和危及生命的疾病。個人化細胞療法從患者體內分離和操縱細胞以產生治療效果。這個新領域有望開發癌症、神經系統疾病、心血管疾病等疾病的治療方法。基因組學、細胞生物學和工程學的進步使科學家能夠更好地了解細胞在健康和疾病中的功能。隨著更多細胞治療產品獲得監管部門核准並應用於臨床實踐，該市場可能會成長。

市場動態：

全球個人化細胞治療市場的成長是由癌症和其他疑難疾病盛行率上升、易患慢性病的老年人口增加、再生醫學的廣泛採用、細胞治療的應用不斷擴大以及生物技術的多種因素所推動的。，包括細胞研究的進展和細胞研究的重大投資。然而，治療成本高、開發週期長以及臨床試驗的監管障礙可能會阻礙市場成長。 iPSC（誘導性多功能幹細胞）技術的持續研究、CAR T細胞療法的採用、同種異體細胞療法的研發以及細胞療法功效的證據的積累為利益相關人員提供了有利的機會。

本研究的主要特點

本報告對全球個人化細胞治療市場進行了詳細分析，包括以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還說明了各個細分市場的潛在商機，並為該市場提供了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球個人化細胞治療市場的主要企業。
據信，這份報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球個人化細胞治療市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球個人化細胞治療市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Thermo Fisher Scientific, Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Pfizer Inc.
- Amgen Inc.
- Bluebird Bio, Inc.
- Personalis, Inc.
- Adaptimmune Therapeutics PLC
- BioNTech SE
- Sangamo Therapeutics, Inc.
- Regeneron Pharmaceuticals, Inc.
- CRISPR Therapeutics AG
- Caribou Biosciences, Inc.
- Mustang Bio, Inc.
- Fate Therapeutics, Inc.
- Atara Biotherapeutics, Inc.
- Holostem Terapie Avanzate Srl

第10章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI204

Global personalized cell therapy market is estimated to be valued at USD 14.12 Bn in 2024 and is expected to reach USD 65.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 24.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 14.12 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	24.40%	2031 Value Projection:	US$ 65.01 Bn

Figure. Personalized Cell Therapy Market Share (%), By Region 2024

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of cells from patient's own body to produce therapeutic effects. This emerging field holds promise for developing curative treatments for cancer, neurological disorders, cardiovascular diseases and others. With advancements in genomics, cell biology and engineering technologies, scientists are gaining deeper understanding of how cells function in healthy and diseased conditions, thus, allowing them to exploit cells' therapeutic potential in a personalized way. The market can witness growth as more cell therapy products receive regulatory approvals and get adopted in clinical practice.

Market Dynamics:

Global personalized cell therapy market growth is driven by several factors such as rising prevalence of cancer and other incurable diseases, growing geriatric population susceptible to chronic illnesses, increasing adoption of regenerative medicines, expanding applications of cell therapies, advances in biotechnology, and heavy investments in cell-based research. However, high treatment costs, long development cycles, and regulatory hurdles surrounding clinical trials can hamper the market growth. Ongoing research on iPSC (induced pluripotent stem cells) technology, adoption of CAR T-cell therapies, development of allogenic cell therapies, growing body of evidence on effectiveness of cell therapies can offer lucrative opportunities for stakeholders.

Key Features of the Study:

This report provides in-depth analysis of the global personalized cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global personalized cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals, Vericel, Pharmicell, Pluristem Therapeutics, BioLineRx, Mesoblast.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global personalized cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized cell therapy market.

Detailed Segmentation-

By Cell Type
- Lymphocytes
- Mesenchymal Stem Cell
- Hematopoietic Stem Cell
- Others
By Therapeutic Area
- Cardiovascular Diseases
- Neurological Disorders
- Inflammatory Diseases
- Diabetes
By End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Thermo Fisher Scientific, Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Pfizer Inc.
- Amgen Inc.
- Bluebird Bio, Inc.
- Personalis, Inc.
- Adaptimmune Therapeutics PLC
- BioNTech SE
- Sangamo Therapeutics, Inc.
- Regeneron Pharmaceuticals, Inc.
- CRISPR Therapeutics AG
- Caribou Biosciences, Inc.
- Mustang Bio, Inc.
- Fate Therapeutics, Inc.
- Atara Biotherapeutics, Inc.
- Holostem Terapie Avanzate S.r.l

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cell Type
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Personalized Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Personalized Cell Therapy Market, By Cell Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Lymphocytes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mesenchymal Stem Cell
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hematopoietic Stem Cell
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Personalized Cell Therapy Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inflammatory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Personalized Cell Therapy Market, By End Users, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Homecare
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Personalized Cell Therapy Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Gilead Sciences, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bluebird Bio, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Personalis, Inc.
  - Company Highlights
  - Therapeutic Area Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Adaptimmune Therapeutics PLC
- BioNTech SE
- Sangamo Therapeutics, Inc.
- Regeneron Pharmaceuticals, Inc.
- CRISPR Therapeutics AG
- Caribou Biosciences, Inc.
- Mustang Bio, Inc.
- Fate Therapeutics, Inc.
- Atara Biotherapeutics, Inc.
- Holostem Terapie Avanzate S.r.l